Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- TNBCIndependent statistical analysis of Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women: Complete Statistical AnalysisIndependent statistical analysis of To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer: Complete Statistical AnalysisIndependent statistical analysis of To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer: primary endpoint…
- To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep.: Complete Statistical AnalysisIndependent statistical analysis of To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered…
- To Compare Safety and Efficacy of Perrigo’s Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis: primary endpoint results, effect estimate with confidence interval,…
- To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel: Complete Statistical AnalysisIndependent statistical analysis of To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel: primary endpoint results, effect estimate with confidence interval,…
- To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin: Complete Statistical AnalysisIndependent statistical analysis of To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00715078).
- To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313): Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.: primary…
- To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days: Complete Statistical AnalysisIndependent statistical analysis of To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma: Complete Statistical AnalysisIndependent statistical analysis of To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler…
- To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study: Complete Statistical AnalysisIndependent statistical analysis of To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Measure Pain Perception Following De-Epithelized Free Gingival Graft Harvesting: Complete Statistical AnalysisIndependent statistical analysis of To Measure Pain Perception Following De-Epithelized Free Gingival Graft Harvesting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03895476).
- To Measure Pain Perception With Electronic Pressure Algometer of Different Size Probes : a Healthy Subjects Research: Complete Statistical AnalysisIndependent statistical analysis of To Measure Pain Perception With Electronic Pressure Algometer of Different Size Probes : a Healthy Subjects Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture: Complete Statistical AnalysisIndependent statistical analysis of To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects: Complete Statistical AnalysisIndependent statistical analysis of To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TOBA II BTKIndependent statistical analysis of Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tobacco Cessation at FDNY: Complete Statistical AnalysisIndependent statistical analysis of Tobacco Cessation at FDNY: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05997225).
- Tobacco Use Treatment in Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Tobacco Use Treatment in Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03482583).
- TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia: Complete Statistical AnalysisIndependent statistical analysis of TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tocilizumab for Patients With Giant Cell Arteritis: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for Patients With Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01450137).
- Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Tocilizumab for the Treatment of Behcet’s Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for the Treatment of Behcet's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01693653).
- TODIndependent statistical analysis of Together Overcoming Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04734015).
- Tofacitinib for the Treatment of Alopecia Areata and Its Variants: Complete Statistical AnalysisIndependent statistical analysis of Tofacitinib for the Treatment of Alopecia Areata and Its Variants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02312882).
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis: Complete Statistical AnalysisIndependent statistical analysis of Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03793439).
- Tolcapone in Obsessive Compulsive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Tolcapone in Obsessive Compulsive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03348930).
- Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin: Complete Statistical AnalysisIndependent statistical analysis of Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops: Complete Statistical AnalysisIndependent statistical analysis of Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02138461).
- Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation): Complete Statistical AnalysisIndependent statistical analysis of Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tolvaptan for Ascites in Cirrhotic Patients: Complete Statistical AnalysisIndependent statistical analysis of Tolvaptan for Ascites in Cirrhotic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01292304).
- TOMOIndependent statistical analysis of Pilot Study Comparing Diagnostic Imaging Versus Tomosynthesis in Detection of Hip, Wrist or Tibia Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TONICIndependent statistical analysis of Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00063635).
- TOP 1501Independent statistical analysis of Neoadjuvant Pembrolizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02818920).
- TOP-UPIndependent statistical analysis of Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TOP1201 IPIIndependent statistical analysis of Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence…
- TOPASIndependent statistical analysis of Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TOPAZIndependent statistical analysis of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.: primary endpoint results, effect estimate with confidence interval, sample-size…
- TOPAZ-1Independent statistical analysis of Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TOPAZ-IIndependent statistical analysis of A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV)…
- TOPCAREIndependent statistical analysis of Targeting Obesity to Optimize Health in Cardiac Rehab (TOPCARE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03423238).
- Topera C-FIRM Registry: Complete Statistical AnalysisIndependent statistical analysis of Topera C-FIRM Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02407249).
- Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02664909).